Worsening stimulant use disorder outcomes coinciding with off-label antipsychotic prescribing: a commonly unrecognised side effect?

Antipsychotic medications exert their effects via dopamine antagonism and are widely used off-label among persons with substance use disorders (SUD). While dopamine antagonists are recognised to stimulate food craving and weight gain, outside of possibly increasing nicotine craving and use, their im...

Descripción completa

Detalles Bibliográficos
Autores principales: Amarasekera, Ruvini, Wood, Evan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Case Reports: Reminder of important clinical lesson
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618975/
https://www.ncbi.nlm.nih.gov/pubmed/37907321
http://dx.doi.org/10.1136/bcr-2023-255129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618975/
https://www.ncbi.nlm.nih.gov/pubmed/37907321
http://dx.doi.org/10.1136/bcr-2023-255129

Ejemplares similares